Qian S, Fu F, Li Y, Gao L, Lu L, Noyola H, Rao A S, Thomson A W, Fung J J
Pittsburgh Transplantation Institute, University of Pittsburgh, Pennsylvania, USA.
Immunology. 1995 May;85(1):82-7.
Livers but not hearts are accepted spontaneously without immunosuppression when transplanted from B10 (KbAbEbDb) to C3H (KkAkEkDk) mice. Both organs however, undergo accelerated rejection in C3H recipients presensitized with B10 skin grafts. In this study, we have investigated further the role of functional cell-surface major histocompatibility complex (MHC class I or class II molecules in allosensitization. Skin from transgenic MHC class I (b2mmlUncbcr; AbEb) or class II (C2DTM, KbDb) gene 'knockout' mice was grafted onto naive recipients 2-3 weeks prior to whole organ transplantation. When C3H hosts were presensitized with skin from C2DTM (class II deficient) mice, they promptly rejected (within 4 days) subsequently transplanted B10 liver or heart allografts. In contrast, presensitization with skin from b2m (beta 2-m mutant; class I deficient) mice did not significantly affect the survival of either organ graft. Maximal sensitization was established by day 14 after skin grafting and persisted for at least 12 weeks. Splenocytes obtained from C3H mice sensitized with skin from B10, B6 (KbAbEbDb), or C2DTM but not from b2m mice exhibited an H-2b-specific cytolytic response when tested in cell-mediated lymphocytotoxicity assays. Sera from C3H mice sensitized with B10 or b2m skin contained high titres of cytotoxic activity specifically against H-2b class I. Taken together, these observations suggest that in the strain combination studied, MHC class I rather than class II molecules play an important role in allosensitization. The results indicate the potential importance of avoiding transplantation of organs into recipients of secondary grafts from donors that share human leucocyte antigen (HLA) class I antigens with the first donor.
当从B10(KbAbEbDb)小鼠移植到C3H(KkAkEkDk)小鼠时,肝脏可在无免疫抑制的情况下被自发接受,但心脏不行。然而,在用B10皮肤移植进行预致敏的C3H受体中,这两种器官都会发生加速排斥反应。在本研究中,我们进一步研究了功能性细胞表面主要组织相容性复合体(MHC I类或II类分子)在同种致敏中的作用。在全器官移植前2 - 3周,将来自转基因MHC I类(b2mmlUncbcr;AbEb)或II类(C2DTM,KbDb)基因“敲除”小鼠的皮肤移植到未致敏的受体上。当C3H宿主用来自C2DTM(II类缺陷)小鼠的皮肤进行预致敏时,它们会迅速(在4天内)排斥随后移植的B10肝脏或心脏同种异体移植物。相比之下,用来自b2m(β2 - m突变体;I类缺陷)小鼠的皮肤进行预致敏对任何一种器官移植物的存活都没有显著影响。皮肤移植后第14天建立最大致敏状态,并持续至少12周。在细胞介导的淋巴细胞毒性试验中进行检测时,从用B10、B6(KbAbEbDb)或C2DTM但不是b2m小鼠的皮肤致敏的C3H小鼠中获得的脾细胞表现出H - 2b特异性细胞溶解反应。用B10或b2m皮肤致敏后的C3H小鼠血清中含有高滴度的针对H - 2b I类的细胞毒性活性。综上所述,这些观察结果表明,在所研究的品系组合中,MHC I类而非II类分子在同种致敏中起重要作用。结果表明,避免将器官移植到与第一个供体共享人类白细胞抗原(HLA)I类抗原的二次移植物受体中的潜在重要性。